Repros Therapeutics (NasdaqGM:RPRX) today announced that the Company has entered into a settlement agreement with its major creditors for the large majority of the debt incurred associated with the recently suspended Proellex® clinical program.
Full Article at TransWorldNews
SANTA ANA, Calif. and ISMANING, Germany, Oct. 7 /PRNewswire-FirstCall/ -- SCM Microsystems Japan, Inc. , a subsidiary of SCM Microsystems, Inc. (Nasdaq: SCMM, Prime Standard: SMY), and Dai Nippon Printing Co. , Ltd.
Full Article at Freshnews.com
We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »